What We're Reading: Page 77
Industry reads hand-picked by our editors
Oct 17, 2023
-
Bloomberg Law
State Drug Pricing Boards Tee Up New Front in Pharma Legal Fight
-
Fierce Biotech
Gilead pays $100M for first dibs on all Assembly Bio assets
-
MedTech Dive
Thermo Fisher buys Olink Holding for $3.1B, pushing further into proteomics
-
The New York Times
Fight Over Covid Lab Leak Stalls Virology Research
Oct 16, 2023
-
Bloomberg
Sickle Cell Gene Therapy Will Test How US Pays for Million-Dollar Cures
-
Axios
Medicare lifts limit on brain scans for Alzheimer’s patients
-
The New York Times
Wearables Track Parkinson’s Better Than Human Observation, Study Finds
-
Boston Business Journal
For biotech entrepreneur Greg Verdine, opportunity just kept knocking
Oct 13, 2023
-
Fierce Biotech
IRA drives Relay to pause plans to win approval in rare cancer
-
Axios
Flagship Pioneering’s Berenson says bad industry outlook will continue
-
Science
Co-developer of Cassava’s potential Alzheimer’s drug cited for ‘egregious misconduct’
-
Bloomberg
JPMorgan Health-Care Dealmaker Robbie Huffines to Retire
Previous
